Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering Type (Consumables, Instruments, Services), By Technology (PCR, ELISA, Flow Cytometry, Plaque Assay, Others), By Application (Blood and Blood Products Manufacturing, Vaccines and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and Tissue Products Manufacturing), By End-User (Life Science Companies, Testing Laboratories, CROs, CDMOs), By Region and Competition, 2020-2030F
Market Overview
The Global Biomanufacturing Viral Detection and Quantifications Market was valued at USD 493.46 million in 2024 and is projected to reach USD 835.86 million by 2030, growing at a CAGR of 9.14%. This market encompasses the large-scale production of reagents, instruments, and diagnostic systems used to detect and quantify viral agents in clinical, environmental, and research samples. Integrating biotechnological, molecular biology, and engineering principles, biomanufacturing enables the consistent and scalable development of tools essential for techniques like PCR, ELISA, and other molecular diagnostics. These technologies support the creation of diagnostic kits and high-throughput platforms, including biosensors and microfluidics, which are increasingly used in point-of-care and laboratory settings. The sector plays a critical role in enabling rapid virus detection and measurement, supporting global health systems in their surveillance, diagnosis, and response efforts. Key areas include molecular diagnostics, immunodiagnostics, biosensor technologies, and cell-based assays—all of which contribute to the timely identification and management of viral threats.
Key Market Drivers
Increasing Incidence of Viral Diseases
The growing prevalence of viral diseases is a primary driver accelerating the demand for advanced viral detection and quantification tools. As of 2024, the World Health Organization reported over 4.2 million dengue cases globally and more than 95,000 mpox (formerly monkeypox) cases since its outbreak in 2022. These figures reflect the increasing urgency for effective diagnostic tools to identify and contain viral infections early.
Biomanufactured products such as PCR kits, ELISA tests, and CRISPR-based diagnostics are vital for fast and accurate virus detection from clinical and environmental samples. These tools facilitate early diagnosis, rapid treatment initiation, and containment of infectious diseases. In settings where diseases like dengue are endemic, early quantification of viral load is essential to assess disease severity and determine appropriate clinical interventions. As new viral threats emerge, the need for deployable, high-performance diagnostic solutions continues to grow.
Key Market Challenges
Rapidly Evolving Viruses
One of the major challenges in the market is the ability of viruses to mutate rapidly, which can compromise the accuracy and reliability of diagnostic assays. Genetic mutations can affect the regions targeted by primers, probes, or antibodies, resulting in false negatives or decreased assay sensitivity.
To maintain diagnostic accuracy, biomanufacturers must continually update assay formulations to account for emerging variants. This requires ongoing investment in R&D and flexible production systems that can respond to evolving viral genomes. Ensuring optimal binding affinity and specificity under these conditions is complex and resource-intensive, posing a challenge to sustained product performance in the face of dynamic viral evolution.
Key Market Trends
Emerging Infectious Diseases Preparedness
Preparedness for emerging infectious diseases (EIDs) is shaping the future of the biomanufacturing viral detection and quantification market. This trend emphasizes the need for agile and responsive diagnostic capabilities that can be deployed during novel outbreaks.
Manufacturers are prioritizing the development of flexible diagnostic platforms that can quickly adapt to new pathogens. Scalable production and modular assay designs enable rapid shifts in manufacturing focus during global health emergencies. Fast-track regulatory approvals, collaborative efforts with public health agencies, and real-time surveillance capabilities are further reinforcing this trend.
Biomanufactured viral detection tools are not only crucial for diagnostics but also for tracking disease spread, evaluating vaccine effectiveness, and informing public health strategies during outbreaks. The growing emphasis on global health security is driving investment in platforms that support EID surveillance, detection, and response.
Key Market Players
Report Scope:
In this report, the Global Biomanufacturing Viral Detection and Quantifications Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Biomanufacturing Viral Detection and Quantifications Market, By Offering Type:
Biomanufacturing Viral Detection and Quantifications Market, By Technology:
Biomanufacturing Viral Detection and Quantifications Market, By Application:
Biomanufacturing Viral Detection and Quantifications Market, By End User:
Biomanufacturing Viral Detection and Quantifications Market, By Region:
North America
Asia-Pacific
Europe
South America
Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Biomanufacturing Viral Detection and Quantifications Market.
Available Customizations:
Global Biomanufacturing Viral Detection and Quantifications Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Global Biomanufacturing Viral Detection and Quantifications Market was valued at USD 493.46 million in 2024 and is projected to reach USD 835.86 million by 2030, growing at a CAGR of 9.14%. This market encompasses the large-scale production of reagents, instruments, and diagnostic systems used to detect and quantify viral agents in clinical, environmental, and research samples. Integrating biotechnological, molecular biology, and engineering principles, biomanufacturing enables the consistent and scalable development of tools essential for techniques like PCR, ELISA, and other molecular diagnostics. These technologies support the creation of diagnostic kits and high-throughput platforms, including biosensors and microfluidics, which are increasingly used in point-of-care and laboratory settings. The sector plays a critical role in enabling rapid virus detection and measurement, supporting global health systems in their surveillance, diagnosis, and response efforts. Key areas include molecular diagnostics, immunodiagnostics, biosensor technologies, and cell-based assays—all of which contribute to the timely identification and management of viral threats.
Key Market Drivers
Increasing Incidence of Viral Diseases
The growing prevalence of viral diseases is a primary driver accelerating the demand for advanced viral detection and quantification tools. As of 2024, the World Health Organization reported over 4.2 million dengue cases globally and more than 95,000 mpox (formerly monkeypox) cases since its outbreak in 2022. These figures reflect the increasing urgency for effective diagnostic tools to identify and contain viral infections early.
Biomanufactured products such as PCR kits, ELISA tests, and CRISPR-based diagnostics are vital for fast and accurate virus detection from clinical and environmental samples. These tools facilitate early diagnosis, rapid treatment initiation, and containment of infectious diseases. In settings where diseases like dengue are endemic, early quantification of viral load is essential to assess disease severity and determine appropriate clinical interventions. As new viral threats emerge, the need for deployable, high-performance diagnostic solutions continues to grow.
Key Market Challenges
Rapidly Evolving Viruses
One of the major challenges in the market is the ability of viruses to mutate rapidly, which can compromise the accuracy and reliability of diagnostic assays. Genetic mutations can affect the regions targeted by primers, probes, or antibodies, resulting in false negatives or decreased assay sensitivity.
To maintain diagnostic accuracy, biomanufacturers must continually update assay formulations to account for emerging variants. This requires ongoing investment in R&D and flexible production systems that can respond to evolving viral genomes. Ensuring optimal binding affinity and specificity under these conditions is complex and resource-intensive, posing a challenge to sustained product performance in the face of dynamic viral evolution.
Key Market Trends
Emerging Infectious Diseases Preparedness
Preparedness for emerging infectious diseases (EIDs) is shaping the future of the biomanufacturing viral detection and quantification market. This trend emphasizes the need for agile and responsive diagnostic capabilities that can be deployed during novel outbreaks.
Manufacturers are prioritizing the development of flexible diagnostic platforms that can quickly adapt to new pathogens. Scalable production and modular assay designs enable rapid shifts in manufacturing focus during global health emergencies. Fast-track regulatory approvals, collaborative efforts with public health agencies, and real-time surveillance capabilities are further reinforcing this trend.
Biomanufactured viral detection tools are not only crucial for diagnostics but also for tracking disease spread, evaluating vaccine effectiveness, and informing public health strategies during outbreaks. The growing emphasis on global health security is driving investment in platforms that support EID surveillance, detection, and response.
Key Market Players
- Danaher Corporation
- Merck KGaA
- New England Biolabs
- TAKARA HOLDINGS INC.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Sartorius AG
- Charles River Laboratories
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc
Report Scope:
In this report, the Global Biomanufacturing Viral Detection and Quantifications Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Biomanufacturing Viral Detection and Quantifications Market, By Offering Type:
- Consumables
- Instruments
- Services
Biomanufacturing Viral Detection and Quantifications Market, By Technology:
- PCR
- ELISA
- Flow Cytometry
- Plaque Assay
- Others
Biomanufacturing Viral Detection and Quantifications Market, By Application:
- Blood and Blood Products Manufacturing
- Vaccines and Therapeutics Manufacturing
- Cellular and Gene Therapy Products Manufacturing
- Stem Cell Products Manufacturing
- Tissue and Tissue Products Manufacturing
Biomanufacturing Viral Detection and Quantifications Market, By End User:
- Life Science Companies
- Testing Laboratories
- CROs and CDMOs
Biomanufacturing Viral Detection and Quantifications Market, By Region:
North America
- United States
- Canada
- Mexico
Asia-Pacific
- China
- India
- South Korea
- Australia
- Japan
Europe
- Germany
- France
- United Kingdom
- Spain
- Italy
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Biomanufacturing Viral Detection and Quantifications Market.
Available Customizations:
Global Biomanufacturing Viral Detection and Quantifications Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Offering Type (Consumables, Instruments, Services)
5.2.2. By Technology (PCR, ELISA, FLOW Cytometry, Plaque Assay, Others)
5.2.3. By Application (Blood and Blood Products Manufacturing, Vaccine and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and tissue Products Manufacturing)
5.2.4. By End-User (Life Science Companies, testing Laboratories, CROs and CDMOs)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. NORTH AMERICA BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Offering Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End-User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Offering Type
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End-User
6.3.2. Mexico Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Offering Type
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End-User
6.3.3. Canada Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Offering Type
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End-User
7. EUROPE BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Offering Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End-User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Offering Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End-User
7.3.2. Germany Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Offering Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End-User
7.3.3. United Kingdom Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Offering Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End-User
7.3.4. Italy Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Offering Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End-User
7.3.5. Spain Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Offering Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End-User
8. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Offering Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End-User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Offering Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End-User
8.3.2. India Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Offering Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End-User
8.3.3. South Korea Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Offering Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End-User
8.3.4. Japan Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Offering Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End-User
8.3.5. Australia Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Offering Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End-User
9. SOUTH AMERICA BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Offering Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Offering Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End-User
9.3.2. Argentina Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Offering Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End-User
9.3.3. Colombia Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Offering Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End-User
10. MIDDLE EAST AND AFRICA BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Offering Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End-User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Offering Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End-User
10.3.2. Saudi Arabia Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Offering Type
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End-User
10.3.3. UAE Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Offering Type
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End-User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. Danaher Corporation
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Merck KGaA
15.3. New England Biolabs
15.4. TAKARA HOLDINGS INC.
15.5. Thermo Fisher Scientific Inc.
15.6. Agilent Technologies, Inc.
15.7. Sartorius AG
15.8. Charles River Laboratories
15.9. Bio-Rad Laboratories, Inc.
15.10. PerkinElmer, Inc
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Offering Type (Consumables, Instruments, Services)
5.2.2. By Technology (PCR, ELISA, FLOW Cytometry, Plaque Assay, Others)
5.2.3. By Application (Blood and Blood Products Manufacturing, Vaccine and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and tissue Products Manufacturing)
5.2.4. By End-User (Life Science Companies, testing Laboratories, CROs and CDMOs)
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. NORTH AMERICA BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Offering Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End-User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Offering Type
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End-User
6.3.2. Mexico Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Offering Type
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End-User
6.3.3. Canada Biomanufacturing Viral Detection and Quantifications Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Offering Type
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End-User
7. EUROPE BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Offering Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End-User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Offering Type
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End-User
7.3.2. Germany Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Offering Type
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End-User
7.3.3. United Kingdom Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Offering Type
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End-User
7.3.4. Italy Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Offering Type
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End-User
7.3.5. Spain Biomanufacturing Viral Detection and Quantifications Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Offering Type
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End-User
8. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Offering Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End-User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Offering Type
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End-User
8.3.2. India Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Offering Type
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End-User
8.3.3. South Korea Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Offering Type
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End-User
8.3.4. Japan Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Offering Type
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End-User
8.3.5. Australia Biomanufacturing Viral Detection and Quantifications Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Offering Type
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End-User
9. SOUTH AMERICA BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Offering Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End-User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Offering Type
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End-User
9.3.2. Argentina Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Offering Type
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End-User
9.3.3. Colombia Biomanufacturing Viral Detection and Quantifications Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Offering Type
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End-User
10. MIDDLE EAST AND AFRICA BIOMANUFACTURING VIRAL DETECTION AND QUANTIFICATIONS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Offering Type
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End-User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Offering Type
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End-User
10.3.2. Saudi Arabia Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Offering Type
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End-User
10.3.3. UAE Biomanufacturing Viral Detection and Quantifications Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Offering Type
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End-User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. PESTLE ANALYSIS
14. PORTER’S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product
15. COMPETITIVE LANDSCAPE
15.1. Danaher Corporation
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Merck KGaA
15.3. New England Biolabs
15.4. TAKARA HOLDINGS INC.
15.5. Thermo Fisher Scientific Inc.
15.6. Agilent Technologies, Inc.
15.7. Sartorius AG
15.8. Charles River Laboratories
15.9. Bio-Rad Laboratories, Inc.
15.10. PerkinElmer, Inc
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
